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Abstract
Use of trait-dependent sampling designs in whole-genome association studies of sequence data can reduce total
sequencing costs with modest losses of statistical efficiency. In a quantitative trait (QT) analysis of data from the
Genetic Analysis Workshop 17 mini-exome for unrelated individuals in the Asian subpopulation, we investigate
alternative designs that sequence only 50% of the entire cohort. In addition to a simple random sampling design,
we consider extreme-phenotype designs that are of increasing interest in genetic association analysis of QTs,
especially in studies concerned with the detection of rare genetic variants. We also evaluate a novel sampling
design in which all individuals have a nonzero probability of being selected into the sample but in which
individuals with extreme phenotypes have a proportionately larger probability. We take differential sampling of
individuals with informative trait values into account by inverse probability weighting using standard survey
methods which thus generalizes to the source population. In replicate 1 data, we applied the designs in
association analysis of Q1 with both rare and common variants in the FLT1 gene, based on knowledge of the
generating model. Using all 200 replicate data sets, we similarly analyzed Q1 and Q4 (which is known to be free of
association with FLT1) to evaluate relative efficiency, type I error, and power. Simulation study results suggest that
the QT-dependent selection designs generally yield greater than 50% relative efficiency compared to using the
entire cohort, implying cost-effectiveness of 50% sample selection and worthwhile reduction of sequencing costs.
Background
We assume an existing cohort of unrelated individuals,
well phenotyped for a quantitative trait (QT) that is
approximately normally distributed. At present, the cost
of whole-genome sequencing of an entire cohort to test
for association remains prohibitive, and selection of a
subset of informative individuals for sequencing is a rea-
sonable strategy to reduce costs. In the absence of rele-
vant genetic information, such as family history or
single-nucleotide polymorphism (SNP) association iden-
tified through genome-wide association studies, one
might hypothesize that individuals at the extremes of
the QT distribution would be more informative for the
detection of association with sequence variants. For
example, individuals with high QT values are more
likely to carry high-risk variants, whereas those with low
values do not. In contrast, taking a simple random sam-
ple from the cohort will tend to select individuals from
the central part of the trait distribution and can fail to
sample individuals with low-frequency variants. Because
ascertainment by the phenotype needs to be taken into
account, simple selection from the tails of the trait dis-
tribution complicates inference. The resulting trait dis-
tribution is bimodal, violating the usual linear regression
assumptions and can produce distorted effect estimates
and type I errors greater or less than nominal. In addi-
tion, the resulting sample is not representative of the
original cohort, making it more difficult to design vali-
dation studies in nonselected populations. Finally, if
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“pathological” then excluding “normal” individuals
would reduce the ability to detect protective variants
associated with favorable QT values. As an alternative,
we propose a sampling design in which all individuals
have a nonzero probability of being selected into the
sample but in which individuals with extreme pheno-
types have a proportionately larger probability of being
selected. We account for differential sampling in the
association analysis by inverse probability weighting
(IPW) with standard survey methods for variance esti-
mation and hypothesis testing. The purpose of our ana-
lyses of the Genetic Analysis Workshop 17 (GAW17)
mini-exome data is to compare alternative sampling
strategies with respect to relative efficiency. We also
examine type I error and power of hypothesis testing.
Methods
Sampling designs
We consider the analysis of sequencing data for the entire
cohort as the ideal against which to compare sampling
designs in which only 50% of the cohort is sequenced.
Four alternative sampling designs are summarized in
Table 1. Extreme-phenotype alternative designs 3 and 4
are systematic and do not actually involve any random
selection; they differ only in whether individuals with “nor-
mal” values are chosen for sequencing. Design 2 involves
simple random sampling (SRS) and thus is expected to be
unbiased compared to the entire cohort, but it has reduced
power and is subject to sampling variation. Under design
5, which is similarly subject to sampling variation, we spe-
cify the sampling probability for each individual according
to the value of their quantitative trait Yi. For individual i,
we use the distance from the median of the trait distribu-
tion (Ymed) in the original cohort:
Δii YY =− med . (1)
In particular, we specify the IPW weight as:
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where Ymax and Ymin are the maximum and minimum
of the Yi, respectively. In design 5.2 extreme observa-
tions are selected more frequently.
Statistical models and hypothesis testing
For common variants, it is feasible to analyze one SNP
at a time. For rare variants, however, methods that accu-
mulate multiple SNP genotypes across a region are
necessary to improve the power to detect association.
We calculate a rare variant score, defined as the total
count of rare alleles within a gene [1,2]. Association
analyses of a QT under designs 1 and 2 are conducted
using standard linear regression methods with the QT
as the dependent variable. To account for unequal sam-
pling probabilities under design 5, we apply IPW in the
linear regression model parameter estimation and use
the R function svyglm from the survey package to esti-
mate appropriate variances and construct a test statistic
[3]. However, because we select observations according
to values of QT, in designs 3, 4, and 5 the validity of
standard linear regression methods is questionable. We
hypothesize that reversing the direction of the regression
is a potentially more robust alternative. As described in
other contexts, reversing the regression has the advan-
tage of conditioning out the phenotype. When analyzing
Table 1 Sampling designs and analytical methods for QT association analysis
Sampling designs Method of analysis Software
Common variant Rare variant score
1. Entire cohort (100%)
2. 50% simple random sample
3. All observations in each of 25% tails
of the QT distribution
4. All observations in each of 20% tails
and central 10% of QT distribution
5. 50% sample by distance from the
median of the QT distribution
a. Linear regression of QT
on genotype
b. Logistic regression of
genotype with QT as
covariate
c. Linear regression of QT on
rare allele count
d. Poisson regression of rare
allele count with QT as
covariate
Designs 1–5: generalized linear regression
(glm) function in R for fitting all models
Design 5 for methods a and c: svyglm
function in R with inverse probability
weights
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tional on the QT value using logistic regression, and
when analyzing a rare variant score, we model the count
conditional on the QT value using Poisson regression.
Application to GAW17 data
We analyze quantitative traits Q1 and Q4 in replicates 1
to 200 of the GAW17 simulated unrelated mini-exome
data [4]. With knowledge of the generating model for
Q 1 ,w ec h o s et h eS N P si nt h eFLT1 gene to compare
methods under a true alternative hypothesis of genetic
association and use analysis of Q4 for comparisons
under the null hypothesis. To reduce heterogeneity and
potential for population stratification bias, we chose the
Asian subpopulations for study: Chinese + Japanese (n =
321).
We excluded SNPs in the FLT1 gene that were mono-
morphic within the Asian subpopulation. Of the 20
remaining SNPs, 18 were classified as rare (all minor
allele frequencies [MAFs] were less than 3.0%); but
according to the generating model, only 6 of these had
functional variants. We calculated a rare variant score
(the count of rare alleles) from the 18 rare SNPs. The
total count of rare alleles per person ranged from 0 to 3
(with corresponding frequencies of 252, 54, 11, and 4).
One SNP with a common functional variant, C13S523,
was analyzed separately (MAF = 8.72% with no rare
homozygotes).
QT-dependent sampling and QT analysis for Q1 and
for Q4 were based on residuals from a linear regression
on Age, Sex and Smoking status. We conducted an
association analysis under each of the five sampling
designs listed in Table 1 in all 200 replicates. Results are
reported for replicate 1 alone to illustrate application of
the methods in a single data set. We summarized distri-
butions of regression coefficients (means and variances),
standard error estimates (means), and test statistics
(type I error and power) across replicates.
Results
Analysis of Q1 with FLT1 SNPs in replicate 1
Association of Q1 with FLT1 was detected at near gen-
ome-wide significance levels for both the common SNP
and the rare variant score (Table 2) using the entire
Asian subpopulation. The logistic regression test statis-
tics are nearly always smaller than the linear regression
test statistics, as expected, because logistic regression is
less efficient for a normally distributed trait. Under lin-
ear regression analysis, association signals for all of the
50% designs were attenuated, with the most attenuation
for designs 2 and 5 and the least attenuation for
extreme-phenotype designs 3 and 4. However, the
regression coefficients for designs 3 and 4 appear to be
inflated. Under logistic regression analysis, design 5 had
the least signal attenuation, and under Poisson regres-
sion it had less signal attenuation when extreme pheno-
types were selected more frequently, as in design 5.2.
Evaluation of test statistics in replicates 1–200
We evaluated type I error at the nominal 5% level by
means of association analysis of Q4 with the FLT1 rare
variant score and common causal variant. With 200
replicates, the 95% confidence interval is roughly 0.05 ±
0.03. For the rare variant score, the linear regression
type I error tended to be less than 5% (Table 3), except
for design 5.2, in which the empirical standard deviation
was larger than the mean standard error (SE), yielding
an elevated type I error. In Poisson regression, type I
Table 2 Results of regression analysis of Q1 with the FLT1 gene in replicate 1
Sampling design Linear regression Poisson regression
Coefficient SE Test statistic p-value Coefficient SE Test statistic p-value
Rare variant score
1 0.44 0.08 5.18 4 × 10
−7 0.60 0.11 5.59 2 × 10
−8
2 0.43 0.11 3.81 2 × 10
−4 0.55 0.13 4.14 3 × 10
−5
3 0.71 0.14 4.94 2 × 10
−6 0.68 0.13 5.26 1 × 10
−7
4 0.80 0.14 5.59 1 × 10
−7 0.79 0.14 5.81 6 × 10
−9
5.1 0.30 0.11 2.82 5 × 10
−3 0.61 0.11 5.37 8 × 10
−8
5.2 0.15 0.10 1.48 0.14 0.63 0.11 5.58 2 × 10
−8
Common variant C13S523
1 1.00 0.12 8.11 1 × 10
−14 1.39 0.21 6.51 8 × 10
−11
2 0.96 0.18 5.24 5 × 10
−7 1.40 0.32 4.36 1 × 10
−5
3 1.67 0.21 7.95 3 × 10
−13 1.66 0.34 4.88 1 × 10
−6
4 1.71 0.21 8.17 9 × 10
−14 1.86 0.37 5.01 5 × 10
−7
5.1 0.90 0.17 5.45 2 × 10
−7 1.39 0.27 5.18 2 × 10
−7
5.2 0.26 0.22 1.16 0.25 1.39 0.26 5.44 5 × 10
−8
P-values are based on the asymptotic distribution of the test statistic.
Yilmaz and Bull BMC Proceedings 2011, 5(Suppl 9):S111
http://www.biomedcentral.com/1753-6561/5/S9/S111
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model SE estimates too small on average. For the com-
mon variant (data not shown), type I error was within
5% for both linear and logistic regressions, except for
design 5.2. In this case, in which the sampling probabil-
ities had a wide range, the survey variance estimation
method applied in the linear regression tended to
underestimate the empirical variance, as also observed
in the rare variant analysis. For logistic regression, how-
ever, design 5.2 was equivalent to designs 3 and 4.
To graphically convey power differences, we con-
structed pairwise comparison plots of design 1 test
statistics for Q1 and the alternative designs in the 200
replicates. We also calculated mean values of the ratio
of the design 1 test statistic over each of the test statis-
tics for the alternative designs that we referred to as the
mean ratio of test statistics (MRT). For the rare variant
score (Figure 1), loss of power under design 2 is readily
apparent in both linear and Poisson regressions. The
scatter observed in designs 2, 5.1, and 5.2 can be
explained partly by the additional variation associated
with the random sampling component. The test statis-
tics for extreme-phenotype designs 3 and 4 were
strongly correlated with those for design 1, with high
Table 3 Simulation results for analysis of Q4 with the FLT1 rare variant score, replicates 1–200
Sampling design Linear regression Poisson regression
Mean coefficient Empirical SD Mean SE Type I error Mean coefficient Empirical SD Mean SE Type I error
1 −0.0014 0.042 0.044 0.040 −0.0089 0.254 0.233 0.075
2 −0.0044 0.060 0.062 0.040 −0.0280 0.364 0.333 0.065
3 −0.0025 0.083 0.086 0.040 −0.0076 0.270 0.246 0.060
4 −0.0031 0.079 0.083 0.030 −0.0127 0.274 0.252 0.050
5.1 −0.0007 0.045 0.046 0.045 −0.0025 0.304 0.281 0.070
5.2 −0.0004 0.051 0.046 0.105 −0.0142 0.274 0.251 0.070
SD, standard deviation. SE, standard error.
Figure 1 Linear (upper panels) and Poisson (lower panels) regression test statistics in Q1 rare variant analysis. MRT, mean ratio of test
statistics.
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designs 5.1, and 5.2 were similarly high. For the com-
mon variant (data not shown), discrepancies with design
1 test statistics were generally similar to those for the
rare variant analysis, with equivalent performance for all
designs under logistic regression but substantial loss of
power.
Evaluation of estimation efficiency using replicates 1–200
Under the null analysis of the rare variant score for Q4,
all estimates were close to being unbiased (Table 3). For
Q 1 ,h o w e v e r ,w h e ne x t r e m e - p h e n o t y p ev a l u e sw e r e
oversampled and this was ignored (under designs 3 and
4), the mean coefficients in the linear regression were
50% larger than those under design 1 (Figure 2). In con-
trast, the mean coefficients for Poisson regression were
similar under designs 1, 3 and 4. Notably, when we
incorporated the sampling probability of each individual
according to the value of their QT, as in sampling
design 5, the mean coefficient was attenuated in the lin-
ear regression but close in value to that for the entire
sample in Poisson regression. Similar findings were
obtained for common variant linear and logistic regres-
sions (data not shown).
To compare designs in terms of precision of estima-
tion, we evaluated relative efficiency (RE), defined as 100
times the ratio of the empirical variance of design 1 to
that of the alternative design (Table 4). This measure
does not depend on SE estimation but may be affected
by differences in the expected value of the regression
coefficient, so we considered the null case of Q4, in
which estimates were approximately unbiased, and the
alternative case of Q1. In comparison to analysis of the
entire cohort, we observed only 40–50% RE under SRS
design 2. Under extreme-phenotype designs 3 and 4, RE
was low for linear regression but high for logistic and
Poisson regression. In contrast, linear regression REs for
Q1 and Q4 were highest for sampling design 5.1, with
an RE of 88% for Q4. However, when extreme observa-
tions were selected with high probability, as in design
5.2, RE was high for logistic and Poisson regression and
comparable to that of designs 3 and 4.
Discussion
As expected, use of a 50% SRS design is not a cost-
effective approach for reducing sequencing costs: The
empirical relative efficiency of estimation was less than
50% in the GAW17 simulations we examined. However,
designs 3–5, in which RE generally exceeded 50% when
conditioning on the QT and could be substantially
higher, appeared to offer a net benefit. The more
extreme IPW sampling design 5.2, which is similar to
designs 3 and 4, behaves similarly, at least for the
regression analyses that condition on the phenotype.
Figure 2 Linear (upper panels) and Poisson (lower panels) regression coefficients in Q1 rare variant analysis
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we applied here may be less than optimal in finite sam-
ples under the alternative hypothesis. Although RE
results for design 5 are encouraging, for hypothesis test-
ing the source of parameter underestimation under the
alternative hypothesis needs to be addressed and SE
estimation improved. Evaluations reported here are lim-
ited, and it is quite possible that sampling and/or
weighting schemes could be improved.
In our extreme-phenotype implementation of designs
3 and 4, we used the observed QT values, in contrast to
more common case-control approaches. Because the lin-
ear regression assumption of normal residuals is grossly
violated, the observed exaggeration of regression coeffi-
cients is not surprising. The lack of elevated type I error
may be ascribed to the use of symmetric tail selection,
but for rare variant analysis there is a clear loss of effi-
ciency. In the GAW17 simulation, in which rare and
common variant effects were generated under an addi-
tive model, differences between designs 3 and 4 were
trivial. In other settings, design 4 may be more robust.
Although it has not been commonly applied, Poisson
regression of allele counts in the rare variant score
appears to be useful as a general approach for single-
gene analysis in many designs, provided that the ten-
dency toward elevated type I error is resolved. For
design 5, Poisson regression avoids the complications of
weighting, because the model conditions on the QT
value.
Conclusions
There is established literature on optimal design for
continuous outcomes in experimental settings and sur-
vey samples, and sampling has been well exploited in
the context of time-to-event outcomes in epidemiologi-
cal designs, such as the case-cohort study [5]. In com-
parison to using the entire cohort, extreme sampling
incurs some loss of efficiency and power to detect asso-
ciation, but it is far more efficient than simple random
sampling of the same number of individuals. Although
our comparisons in the GAW17 data do not conform to
aw h o l l yr e a l i s t i cs e t t i n gi nt e r m so fs a m p l es i z ea n d
volume of sequencing data, they do suggest that QT-
dependent sampling can be quite effective in reducing
sequencing costs with developing prospects for whole-
genome sequencing.
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Q4 Q1 Q4 Q1 Q4 Q1 Q4 Q1
2 5 04 14 94 34 64 64 54 5
3 2 63 68 97 02 65 58 75 0
4 2 93 48 66 82 65 07 85 3
5.1 88 62 70 53 88 57 72 46
5.2 70 44 86 76 56 31 84 52
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